01 1Ipca Laboratories
01 1LOSARTAN POTASSIUM USP (LB4 PROCESS)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-12-05
Pay. Date : 2024-11-14
DMF Number : 40760
Submission : 2024-10-30
Status : Active
Type : II
20
Ipca Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LOSARTAN POTASSIUM USP (LB4 PROCESS), with a corresponding US DMF Number 40760.
Remarkably, this DMF maintains an Active status since its submission on October 30, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 05, 2024, and payment made on November 14, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
